Charles Schwab Investment Management Inc Vir Biotechnology, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,134,276 shares of VIR stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,134,276

Previous 998,189 13.63%

Holding current value

$12.4 Million

Previous $8.88 Million 4.37%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.26 - $10.7 $987,991 - $1.46 Million	136,087 Added 13.63%	1,134,276 $8.5 Million
Q2 2024 Aug 12, 2024	BUY	$7.63 - $12.66 $1.29 Million - $2.14 Million	168,878 Added 20.36%	998,189 $8.88 Million
Q1 2024 May 08, 2024	BUY	$8.6 - $11.9 $655,646 - $907,232	76,238 Added 10.12%	829,311 $8.4 Million
Q4 2023 Feb 06, 2024	BUY	$7.76 - $10.29 $243,702 - $323,157	31,405 Added 4.35%	753,073 $7.58 Million
Q3 2023 Nov 08, 2023	BUY	$9.14 - $24.62 $774,103 - $2.09 Million	84,694 Added 13.3%	721,668 $6.76 Million
Q2 2023 Aug 09, 2023	BUY	$23.2 - $27.29 $622,154 - $731,835	26,817 Added 4.4%	636,974 $15.6 Million
Q1 2023 May 11, 2023	SELL	$22.26 - $30.85 $2.77 Million - $3.84 Million	-124,590 Reduced 16.96%	610,157 $14.2 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $1.66 Million - $2.35 Million	83,374 Added 12.8%	734,747 $18.6 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $2.16 Million - $3.68 Million	-118,191 Reduced 15.36%	651,373 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $462,422 - $647,101	24,236 Added 3.25%	769,564 $19.6 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $398,202 - $751,867	18,792 Added 2.59%	745,328 $19.2 Million
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $863,815 - $1.51 Million	27,892 Added 3.99%	726,536 $30.4 Million
Q3 2021 Nov 16, 2021	BUY	$34.9 - $54.54 $3.85 Million - $6.01 Million	110,188 Added 18.72%	698,644 $30.4 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $1.21 Million - $1.6 Million	31,284 Added 5.61%	588,456 $27.8 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $389,858 - $1.23 Million	14,801 Added 2.73%	557,172 $28.6 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $151,427 - $257,503	5,936 Added 1.11%	542,371 $14.5 Million
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $12.3 Million - $23.4 Million	435,872 Added 433.43%	536,435 $18.4 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $2.38 Million - $4.09 Million	85,366 Added 561.73%	100,563 $4.12 Million
Q1 2020 May 15, 2020	SELL	$12.04 - $60.2 $3,238 - $16,193	-269 Reduced 1.74%	15,197 $521,000
Q4 2019 Feb 07, 2020	BUY	$11.83 - $15.85 $182,962 - $245,136	15,466 New	15,466 $195,000

Others Institutions Holding VIR

# of Institutions

214

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.45B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Vir Biotechnology, Inc. Transaction History